Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

BDTXBDTX
Showing 8 of 26 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in BLACK DIAMOND THERAPEUTICS I

GEODE CAPITAL MANAGEMENT, LLC holds 1.2M shares of BDTX (BLACK DIAMOND THERAPEUTICS I), worth $2.3M as of 2026-Q2. The position was increased (+127.0% shares). BDTX represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$2.3M

Current Shares

1.2M

Total Value Change

-$1.9M

Total Shares Change

+273,294

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.2M
+127.0%
$2.3M0.0%$1.85
42
2026-Q1
Increased
536,575
+6.1%
$1.1M0.0%$2.30
27
2025-Q4
Increased
505,780
+1.1%
$1.2M0.0%$2.49
25
2025-Q3
Increased
500,523
+1.1%
$1.9M0.0%$3.73
26
2025-Q2
Decreased
495,343
-48.7%
$1.2M0.0%$2.35
0
2025-Q1
Increased
965,599
+0.7%
$1.5M0.0%$1.61
26
2024-Q4
Increased
959,316
+1.5%
$2.1M0.0%$2.15
26
2024-Q3
Increased
944,877
+12.2%
$4.1M0.0%$4.23
30

Other major holders of BDTX: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used